The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
Ceased 5
  • 1
    Moore-thornicroft, Storme Jo-anne
    Individual (6 offsprings)
    Officer
    2003-12-05 ~ 2014-10-03
    OF - secretary → CIF 0
  • 2
    Khagram, Pravin
    Individual (14 offsprings)
    Officer
    1996-07-29 ~ 2003-12-05
    OF - secretary → CIF 0
  • 3
    Bradman, Neil Nathan
    Chartered Accountant born in October 1941
    Individual (15 offsprings)
    Officer
    1996-07-29 ~ 2003-12-05
    OF - director → CIF 0
  • 4
    26, Church Street, London
    Dissolved corporate (4 parents, 10 offsprings)
    Equity (Company account)
    2 GBP2022-12-31
    Officer
    1996-07-29 ~ 1996-07-29
    PE - nominee-secretary → CIF 0
  • 5
    1, Mitchell Lane, Bristol, Avon
    Dissolved corporate (4 parents, 15 offsprings)
    Equity (Company account)
    100 GBP2022-12-31
    Officer
    1996-07-29 ~ 1996-07-29
    PE - nominee-director → CIF 0
parent relation
Company in focus

LASCAUX PHARMACEUTICALS LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Turnover/Revenue
13,220 GBP2022-10-01 ~ 2023-09-30
Expenses related to depreciation, amortization, and impairment of assets
-3,603 GBP2022-10-01 ~ 2023-09-30
-3,604 GBP2021-10-01 ~ 2022-09-30
Profit/Loss
8,935 GBP2022-10-01 ~ 2023-09-30
-45,947 GBP2021-10-01 ~ 2022-09-30
Fixed Assets
4,056 GBP2023-09-30
7,660 GBP2022-09-30
Current Assets
7,253 GBP2023-09-30
3,610 GBP2022-09-30
Creditors
Amounts falling due within one year
-650 GBP2023-09-30
Net Current Assets/Liabilities
6,603 GBP2023-09-30
3,610 GBP2022-09-30
Total Assets Less Current Liabilities
10,659 GBP2023-09-30
11,270 GBP2022-09-30
Creditors
Amounts falling due after one year
-51,380 GBP2023-09-30
-60,926 GBP2022-09-30
Net Assets/Liabilities
-40,721 GBP2023-09-30
-49,656 GBP2022-09-30
Equity
-40,721 GBP2023-09-30
-49,656 GBP2022-09-30
Average Number of Employees
02022-10-01 ~ 2023-09-30

  • LASCAUX PHARMACEUTICALS LIMITED
    Info
    Registered number 03230603
    2a Dunmore Court Lascaux Pharma, 2a Dunmore Court, Wootton Road, Abingdon, Oxon OX13 6BH
    Private Limited Company incorporated on 1996-07-29 (28 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-29
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.